| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1080/10428190500155603 |
| P698 | PubMed publication ID | 16194884 |
| P2093 | author name string | Nachbaur D | |
| Kircher B | |||
| P2860 | cites work | In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas | Q24652833 |
| Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation | Q24677534 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood | Q28138201 | ||
| Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation | Q28209687 | ||
| Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
| Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset | Q28290931 | ||
| Tolerogenic dendritic cells | Q29618755 | ||
| Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants | Q29619458 | ||
| Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms | Q33195020 | ||
| Dendritic cells as a tool to induce anergic and regulatory T cells | Q34295082 | ||
| Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis | Q34337007 | ||
| Dendritic cells as vectors for therapy | Q34339199 | ||
| Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? | Q34430882 | ||
| Active immunization against cancer with dendritic cells: the near future | Q34464304 | ||
| The interaction of fungi with dendritic cells: implications for Th immunity and vaccination | Q34873583 | ||
| Cellular immunity to viral and fungal antigens after stem cell transplantation | Q34977548 | ||
| The use of dendritic cells in cancer immunotherapy | Q35084257 | ||
| Effects of immunosuppressive drugs on dendritic cells and tolerance induction | Q35159612 | ||
| Graft-versus-leukemia reactions in allogeneic chimeras | Q35213001 | ||
| Dendritic cells and fungi | Q35219327 | ||
| Dendritic cells: emerging pharmacological targets of immunosuppressive drugs | Q35620073 | ||
| Hematopoietic cell transplantation: five decades of progress | Q35633969 | ||
| Dendritic cell-based vaccination against opportunistic fungi | Q35710159 | ||
| Minor histocompatibility antigens--big in tumour therapy | Q35753092 | ||
| CMV-specific immunotherapy | Q35789375 | ||
| Dendritic cell-mediated T cell polarization | Q35988802 | ||
| Human dendritic cells. Enrichment and characterization from peripheral blood | Q36346337 | ||
| Interferon alpha/beta and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo | Q36369895 | ||
| Langerhans cells renew in the skin throughout life under steady-state conditions | Q36505129 | ||
| Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease | Q36505142 | ||
| Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease | Q39737912 | ||
| Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen. | Q40470166 | ||
| Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4. | Q40517084 | ||
| Cyclosporine preconditions dendritic cells during differentiation and reduces IL-2 and IL-12 production following activation: a potential tolerogenic effect | Q40550311 | ||
| Tumor vaccination after allogeneic bone marrow cell reconstitution of the nonmyeloablatively conditioned tumor-bearing murine host | Q40609227 | ||
| Characterization of human blood dendritic cell subsets | Q40625943 | ||
| Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects | Q40706569 | ||
| Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy | Q40732151 | ||
| Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants | Q40871585 | ||
| Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis | Q41283113 | ||
| Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy | Q41561713 | ||
| Cytokine cascades in acute graft-versus-host disease | Q41592255 | ||
| Inhibition of human dendritic cell functions by methylprednisolone. | Q42473073 | ||
| Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality | Q43564442 | ||
| Decreased yield, phenotypic expression and function of immature monocyte-derived dendritic cells in cord blood | Q43591864 | ||
| Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma | Q43636296 | ||
| Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells. | Q43720658 | ||
| Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients | Q43893055 | ||
| Peripheral blood stem cell harvests from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells | Q44006790 | ||
| Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells | Q44072016 | ||
| Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics | Q44077298 | ||
| Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants | Q44118783 | ||
| The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation | Q44182914 | ||
| APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease | Q44241989 | ||
| Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo | Q44280916 | ||
| Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma | Q44351254 | ||
| Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease | Q44372688 | ||
| Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate–pulsed dendritic cells | Q44417153 | ||
| Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells | Q44585204 | ||
| A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia | Q44592663 | ||
| Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand | Q44756910 | ||
| Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis | Q44969235 | ||
| Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells | Q44986020 | ||
| Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival | Q45219593 | ||
| Dendritic cells transduced with an adenovirus vector encoding interleukin-12 are a potent vaccine for invasive pulmonary aspergillosis | Q45880890 | ||
| Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease | Q47371499 | ||
| Phenotype, function and chimaerism of monocyte‐derived blood dendritic cells after allogeneic haematopoietic stem cell transplantation | Q47604670 | ||
| Immunophenotypic and functional characterization of cord blood dendritic cells | Q47805839 | ||
| Blood dendritic cells are decreased in acute graft-versus-host disease | Q47818035 | ||
| Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation. | Q47977196 | ||
| Overview of transplant activity in Europe. | Q50745120 | ||
| Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants. | Q52020479 | ||
| A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation | Q53927810 | ||
| Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. | Q53963043 | ||
| Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. | Q53977124 | ||
| Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. | Q54451826 | ||
| Editorial overview | Q57598926 | ||
| Dendritic Cells Transport Conidia and Hyphae of Aspergillus fumigatus from the Airways to the Draining Lymph Nodes and Initiate Disparate Th Responses to the Fungus | Q58855400 | ||
| P433 | issue | 10 | |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 1387-1396 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | Dendritic cells in allogeneic hematopoietic stem cell transplantation | |
| P478 | volume | 46 |
| Q36446933 | Biological response modifiers as adjuncts to stem cell transplantation. |
| Q47123396 | CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results |
| Q63386759 | Dendritic cell reconstitution is associated with relapse-free survival and acute GVHD severity in children after allogeneic stem cell transplantation |
| Q35016985 | HDAC inhibition and graft versus host disease |
| Q84848296 | Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function |
| Q36593312 | Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications |
| Q37026059 | Targeting deacetylases to improve outcomes after allogeneic bone marrow transplantation |
Search more.